Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

IMAImageneBio, Inc.

Nasdaq · CIK 0001835579
Filer category<br>Emerging growth company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts318

Identity from submissions API

NameImageneBio, Inc.
CIK0001835579
TickersIMA
ExchangesNasdaq
Entity typeoperating
Category<br>Emerging growth company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN811697316
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone857-343-8292
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Ikena Oncology, Inc. (2021-01-08T00:00:00.000Z → 2025-07-25T00:00:00.000Z)
Business address
12526 HIGH BLUFF DRIVE
SAN DIEGO
CA
92130
CA
Mailing address
12526 HIGH BLUFF DRIVE
SAN DIEGO
CA
92130
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

339 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001140361-26-043771 005-92449 261553105 34 7969
2026-11-09 8-K 8-K 2.02,9.01 0001193125-26-453639 001-40287 261536212 34 247206 1 1
2026-11-09 10-Q 10-Q 0001193125-26-453624 001-40287 261536161 34 10464828 1 1
2026-08-17 4 xslF345X06/form4-08172026_050803.xml 0001803794-26-000003 10178
2026-08-17 4 xslF345X06/form4-08172026_050801.xml 0002064348-26-000003 9963
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000921895-26-002168 005-92449 261281487 34 25200
2026-08-11 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002625 333-298008 261265140 33 1818
2026-08-11 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002624 333-298002 261265136 33 1818
2026-08-06 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002555 333-290108 261251214 33 1831
2026-08-05 S-8 S-8 0001193125-26-335229 333-298010 261244002 33 185170 1 1
2026-08-05 S-3 S-3 0001193125-26-335213 333-298008 261243958 33 1446159 1 1
2026-08-05 POS AM POS AM 0001193125-26-335203 333-290108 261243904 33 231804
2026-08-05 424B3 424B3 0001193125-26-335180 333-290108 261243858 33 1717069
2026-08-05 S-3 S-3 0001193125-26-335163 333-298002 261243796 33 386185 1 1
2026-08-05 10-Q 10-Q 0001193125-26-333920 001-40287 261241422 34 9441652 1 1
2026-08-05 8-K 8-K 2.02,9.01 0001193125-26-333912 001-40287 261241411 34 256310 1 1
2026-07-28 3 xslF345X06/form3-07282026_080744.xml 0002064348-26-000002 10593
2026-07-28 4 xslF345X06/form4-07282026_040701.xml 0001803794-26-000002 11900
2026-07-23 424B3 424B3 0001193125-26-314180 333-290108 261197363 33 158066
2026-07-23 8-K 8-K 5.02,8.01,9.01 0001193125-26-314167 001-40287 261197343 34 313111 1 1
2026-07-20 4 xslF345X06/form4-07212026_010709.xml 0002126940-26-000004 7284
2026-06-29 424B3 424B3 0001193125-26-286817 333-290108 261131287 33 28376
2026-06-26 8-K 8-K 5.02 0001193125-26-285424 001-40287 261128929 34 141400 1 1
2026-06-18 4 xslF345X06/form4-06182026_060606.xml 0001555242-26-000002 5683
2026-06-18 4 xslF345X06/form4-06182026_060604.xml 0001361712-26-000002 5663
2026-06-18 4 xslF345X06/form4-06182026_060603.xml 0001246530-26-000004 5688
2026-06-18 4 xslF345X06/form4-06182026_060601.xml 0001572451-26-000005 5699
2026-06-17 424B3 424B3 0001193125-26-274147 333-290108 261098443 33 209440
2026-06-17 8-K 8-K 5.02,5.07,9.01 0001193125-26-274139 001-40287 261098359 34 372397 1 1
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000921895-26-001396 005-92449 26987461 34 23745
2026-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001140361-26-021307 005-92449 26979202 34 7544
2026-05-08 424B3 424B3 0001193125-26-212796 333-290108 26955675 33 2265078
2026-05-07 424B3 424B3 0001193125-26-212458 333-290108 26954956 33 12338
2026-05-07 10-Q 10-Q 0001193125-26-212073 001-40287 26953923 34 8278493 1 1
2026-05-07 8-K 8-K 2.02,9.01 0001193125-26-211935 001-40287 26953420 34 221490 1 1
2026-04-30 ARS ARS 0001140361-26-018276 001-40287 26926241 34 2923261
2026-04-30 DEFA14A DEFA14A 0001140361-26-018272 001-40287 26926218 34 4369270
2026-04-30 DEF 14A DEF 14A 0001140361-26-018267 001-40287 26926178 34 4983051 1 1
2026-04-29 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0000947871-26-000483 005-92449 26919045 34 39420
2026-04-21 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001493152-26-018316 005-92449 26879913 34 25344
2026-04-21 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001193125-26-166691 005-92449 26879227 34 135944
2026-04-20 3 xslF345X06/form3-04202026_090434.xml 0002126940-26-000002 13388
2026-04-16 3 xslF345X06/form3-04162026_110416.xml 0002113925-26-000001 3336
2026-04-16 4 xslF345X06/ownership.xml 0000947871-26-000449 12402
2026-04-16 4 xslF345X06/ownership.xml 0000947871-26-000448 16339
2026-04-13 424B3 424B3 0001193125-26-152036 333-290108 26856527 33 466581
2026-04-13 8-K 8-K 1.01,3.02,9.01 0001193125-26-151942 001-40287 26856424 34 693365 1 1
2026-04-03 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001080 333-290108 26839463 33 1830
2026-04-02 POS AM POS AM 0001193125-26-140536 333-290108 26835456 33 19559058
2026-03-18 4 xslF345X06/form4-03182026_100308.xml 0001803794-26-000001 7985
2026-03-17 8-K 8-K 5.02 0001193125-26-110945 001-40287 26762509 34 143822 1 1
2026-03-10 S-8 S-8 0001193125-26-099489 333-294174 26737471 33 206580 1 1
2026-03-10 10-K 10-K 0001193125-26-099434 001-40287 26737354 34 17207408 1 1
2026-03-10 8-K 8-K 2.02,9.01 0001193125-26-099422 001-40287 26737298 34 238872 1 1
2026-02-20 3 xslF345X02/form3-02202026_090223.xml 0002106853-26-000001 10294
2026-02-17 424B3 424B3 0001193125-26-054697 333-290108 26641583 33 29096
2026-02-17 8-K 8-K 5.02 0001193125-26-054684 001-40287 26641496 34 140503 1 1
2026-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-26-000716 005-92449 26629109 34 11372
2026-02-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001140361-26-005001 005-92449 26626269 34 7463
2026-01-06 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002073679-26-000001 005-92449 26512285 34 102795
2026-01-02 4 xslF345X05/form4-01032026_020151.xml 0001940413-26-000001 7693
2025-12-29 4 xslF345X05/form4-12292025_091224.xml 0001246530-25-000007 4641
2025-12-22 4 xslF345X05/form4-12222025_101230.xml 0001555242-25-000005 5860
2025-12-22 4 xslF345X05/form4-12222025_101213.xml 0002088597-25-000003 5878
2025-12-22 4 xslF345X05/form4-12222025_101250.xml 0001246530-25-000006 5865
2025-12-18 424B3 424B3 0001193125-25-324808 333-290108 251583100 33 26508
2025-12-18 8-K 8-K 5.02 0001193125-25-324798 001-40287 251583053 34 140428 1 1
2025-11-19 8-K 8-K 7.01,9.01 0001193125-25-286984 001-40287 251496659 34 11495853 1 1
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000921895-25-003102 005-92449 251486124 34 23566
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001140361-25-042297 005-92449 251485818 34 6876
2025-11-12 S-8 S-8 0001193125-25-276225 333-291449 251469648 33 251504 1 1
2025-11-12 424B3 424B3 0001193125-25-276159 333-290108 251469417 33 2707728
2025-11-12 10-Q 10-Q 0001193125-25-275932 001-40287 251468851 34 11424087 1 1
2025-11-12 8-K 8-K 2.02,9.01 0001193125-25-275910 001-40287 251468829 34 252232 1 1
2025-11-07 3 xslF345X02/form3-11072025_101136.xml 0001246530-25-000004 9992
2025-11-05 424B3 424B3 0001193125-25-266915 333-290108 251453961 33 26934
2025-11-05 8-K 8-K 5.02 0001193125-25-266889 001-40287 251453868 34 141177 1 1
2025-10-30 424B3 424B3 0001193125-25-258697 333-290108 251436275 33 60668
2025-10-29 8-K 8-K 1.01,1.02 0001193125-25-254697 001-40287 251426897 34 141888 1 1
2025-10-22 8-K 8-K 5.02 0001193125-25-245823 001-40287 251408737 34 141001 1 1
2025-10-10 8-K 8-K 5.02 0001193125-25-237161 001-40287 251388532 34 140234 1 1
2025-10-10 4 xslF345X05/form4-10102025_081012.xml 0002088597-25-000002 11622
2025-10-10 3 xslF345X02/form3-10102025_081055.xml 0002088597-25-000001 10126
2025-09-15 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002967 333-290108 251315652 33 1818
2025-09-11 CORRESP filename1.htm 0001193125-25-201427 6699
2025-09-11 UPLOAD filename1.pdf 0000000000-25-009873 333-290108 40103
2025-09-08 S-1 S-1 0001193125-25-198360 333-290108 251300217 33 27023131 1 1
2025-08-15 4 xslF345X05/form4-08152025_080852.xml 0001415889-25-022091 8723
2025-08-15 3 xslF345X02/form3-08152025_080854.xml 0001415889-25-022090 10006
2025-08-12 8-K/A 8-K/A 2.01,9.01 0001193125-25-179093 001-40287 251207985 34 789778 1 1
2025-08-07 4 xslF345X05/form4-08072025_090807.xml 0001415889-25-021290 15359
2025-08-07 3 xslF345X02/form3-08072025_090853.xml 0001415889-25-021289 10045
2025-08-05 8-K 8-K 4.01,9.01 0001193125-25-173626 001-40287 251186177 34 152824 1 1
2025-08-04 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-002868 005-92449 251180815 34 11211
2025-08-04 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-002867 005-92449 251180761 34 11322
2025-08-01 8-K 8-K 5.02,8.01,9.01 0001193125-25-171747 001-40287 251176931 34 409714 1 1
2025-07-30 4 xslF345X05/form4-07312025_010741.xml 0001415889-25-020660 8175
2025-07-30 4 xslF345X05/ownership.xml 0000947871-25-000712 13447
2025-07-30 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000947871-25-000711 005-92449 251168990 34 36035
2025-07-30 4 xslF345X05/form4-07302025_080741.xml 0001415889-25-020601 23946
2025-07-30 4 xslF345X05/form4-07302025_080705.xml 0001415889-25-020598 19404
2025-07-29 4 4 0000950170-25-099848 12263
2025-07-29 4 xslF345X05/form4-07292025_110730.xml 0001415889-25-020511 8736
2025-07-29 3 xslF345X02/form3-07292025_100732.xml 0001415889-25-020509 9635
2025-07-29 3 xslF345X02/form3-07292025_100726.xml 0001415889-25-020508 10073
2025-07-29 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001415889-25-020462 005-92449 251162457 34 60396
2025-07-29 8-K 8-K 1.01,2.01,3.02,3.03,5.01,5.02,5.03,5.06,7.01,9.01 0001193125-25-167089 001-40287 251157404 34 16278038 1 1
2025-07-28 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001373604-25-000095 005-92449 251155055 34 11099
2025-07-25 8-K 8-K 7.01,9.01 0001193125-25-165170 001-40287 251150444 34 224483 1 1
2025-07-24 10-Q 10-Q 0000950170-25-098414 001-40287 251147896 34 7923127 1 1
2025-07-24 8-K 8-K 8.01 0001193125-25-163990 001-40287 251144766 34 156700 1 1
2025-07-22 8-K 8-K 8.01 0001193125-25-162584 001-40287 251140533 34 153584 1 1
2025-07-18 D xslFormDX01/primary_doc.xml 06b 0001470831-25-000095 021-552269 251134446 33 14010
2025-07-16 8-K 8-K 5.02 0001193125-25-159910 001-40287 251127856 34 146622 1 1
2025-07-15 8-K 8-K 5.02,5.07,8.01,9.01 0001193125-25-159400 001-40287 251125333 34 248239 1 1
2025-07-11 425 425 0001193125-25-157869 001-40287 251117591 34 53894
2025-07-11 8-K 8-K 8.01,9.01 0001193125-25-157867 001-40287 251117583 34 193775 1 1
2025-07-01 425 425 0001193125-25-154022 001-40287 251096582 34 61617
2025-07-01 8-K 8-K 7.01,8.01,9.01 0001193125-25-154016 001-40287 251096530 34 201664 1 1
2025-06-18 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000947871-25-000619 005-92449 251058737 34 40548
2025-06-16 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001373604-25-000088 005-92449 251049111 34 13825
2025-06-11 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001888 333-285881 251041565 33 1711
2025-06-11 424B3 424B3 0001140361-25-022216 333-285881 251040806 33 18380987
2025-06-10 CORRESP filename1.htm 0001140361-25-022073 10046
2025-06-09 S-4/A S-4/A 0001140361-25-021863 333-285881 251032829 33 18590608
2025-06-09 CORRESP filename1.htm 0001140361-25-021864 528810
2025-06-03 UPLOAD filename1.pdf 0000000000-25-005870 333-285881 43762
2025-05-30 S-4/A S-4/A 0001140361-25-020955 333-285881 251011771 33 18584506
2025-05-20 S-4/A S-4/A 0001140361-25-019918 333-285881 25969774 33 39464820 1 1
2025-05-08 10-Q 10-Q 0000950170-25-066411 001-40287 25923956 34 6766298 1 1
2025-05-07 CORRESP filename1.htm 0001140361-25-017706 19784
2025-05-07 S-4/A S-4/A 0001140361-25-017705 333-285881 25921625 33 17336367
2025-05-02 UPLOAD filename1.pdf 0000000000-25-004691 333-285881 45962
2025-04-21 CORRESP filename1.htm 0001140361-25-014763 578452
2025-04-21 S-4/A S-4/A 0001140361-25-014758 333-285881 25853884 33 17406007
2025-04-14 UPLOAD filename1.pdf 0000000000-25-003953 333-285881 66021
2025-03-18 S-4 S-4 0001140361-25-009263 333-285881 25748606 33 35704861 1 1
2025-03-06 ARS ARS 0001193125-25-047915 001-40287 25713700 34 982850
2025-03-06 10-K 10-K 0000950170-25-034188 001-40287 25713676 34 13280848 1 1
2025-02-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-001189 005-92449 25629749 34 11123
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000921895-25-000492 005-92449 25629314 34 23483
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001373604-25-000033 005-92449 25624736 34 8517
2025-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001123292-25-000081 005-92449 25620612 34 6557
2025-01-10 425 425 0001193125-25-004044 001-40287 25520252 34 28851
2024-12-31 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001373604-24-000124 005-92449 241592858 34 7801
2024-12-23 425 425 0001193125-24-283726 001-40287 241570209 34 6141309
2024-12-23 8-K 8-K 1.01,3.02,5.01,5.02,7.01,9.01 0001193125-24-283722 001-40287 241570203 34 6954428 1 1
2024-11-14 SC 13G SC 13G 0001140361-24-046970 005-92449 241464093 34 51964
2024-11-13 SC 13G/A SC 13G/A 0001140361-24-046454 005-92449 241454002 34 91048
2024-11-07 10-Q 10-Q 0000950170-24-122818 001-40287 241433265 34 6673367 1 1
2024-08-08 10-Q 10-Q 0000950170-24-093880 001-40287 241188161 34 6396327 1 1
2024-07-12 8-K 8-K 5.02 0001193125-24-178568 001-40287 241114517 34 154968 1 1
2024-06-10 4 4 0000950170-24-071303 5901
2024-06-10 4 4 0000950170-24-071308 5273
2024-06-10 4 4 0000950170-24-071302 5285
2024-06-10 4 4 0000950170-24-071307 5241
2024-06-10 4 4 0000950170-24-071301 5263
2024-06-10 4 4 0000950170-24-071306 5290
2024-06-10 4 4 0000950170-24-071305 5252
2024-06-10 8-K 8-K 5.07 0001193125-24-158321 001-40287 241032691 34 158518 1 1
2024-05-28 8-K 8-K 2.05,7.01,8.01,9.01 0001193125-24-148112 001-40287 24992213 34 9102504 1 1
2024-05-13 10-Q 10-Q 0000950170-24-058715 001-40287 24939643 34 5580175 1 1
2024-04-26 ARS ARS 0001193125-24-118200 001-40287 24884469 34 2757492
2024-04-26 DEFA14A DEFA14A 0001193125-24-118164 001-40287 24884376 34 451554
2024-04-26 DEF 14A DEF 14A 0001140361-24-022470 001-40287 24884148 34 2216121
2024-03-12 S-8 S-8 0001193125-24-065414 333-277833 24740223 33 65512
2024-03-12 10-K 10-K 0000950170-24-029651 001-40287 24740190 34 14138517 1 1
2024-03-11 SC 13G/A filing.txt 0000315066-24-001680 005-92449 24736620 34 8144
2024-03-05 4 4 0000950170-24-025870 5278
2024-03-05 3 3 0000950170-24-025849 14175
2024-02-21 8-K 8-K 5.02,7.01,9.01 0001193125-24-041504 001-40287 24660044 34 236257 1 1
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-023937 005-92449 24639957 34 137711
2024-02-14 SC 13G/A SC 13G/A 0001193125-24-036445 005-92449 24639728 34 130213
2024-02-14 SC 13G/A AMENDMENT NO. 3 TO SCHEDULE 13G 0000921895-24-000445 005-92449 24633277 34 277325
2024-02-09 SC 13G/A filing.txt 0000315066-24-001261 005-92449 24611784 34 8077
2024-02-02 4 4 0000950170-24-010623 5274
2024-02-02 4 4 0000950170-24-010601 5292
2024-02-02 4 4 0000950170-24-010599 5225
2024-01-18 8-K 8-K 2.02,2.05,7.01,8.01,9.01 0001193125-24-010227 001-40287 24542165 34 187089 1 1
2023-11-09 10-Q 10-Q 0000950170-23-061535 001-40287 231390070 34 8654081 1 1
2023-11-09 8-K 8-K 2.02,8.01,9.01 0000950170-23-061519 001-40287 231390022 34 424840 1 1
2023-10-19 SC 13G OCT 2023 FILING, IKENA ONC AS ISSUER FOR GILEAD SCIENCES, THE REPORTING PERSON 0000904454-23-000572 005-92449 231334629 34 49780
2023-10-11 8-K 8-K 5.07 0001140361-23-047880 001-40287 231321297 34 176370 1 1
2023-09-25 DEF 14A DEF 14A 0001140361-23-045091 001-40287 231275913 34 1858734
2023-09-21 4/A xslF345X05/ownership.xml 0000947871-23-000952 13652
2023-09-21 4/A xslF345X05/ownership.xml 0000947871-23-000951 17359
2023-09-21 SC 13D/A AMENDMENT NO. 3 0000947871-23-000950 005-92449 231269593 34 153371
2023-09-15 PRE 14A PRE 14A 0001140361-23-044145 001-40287 231258730 34 1701061
2023-09-14 4 xslF345X05/ownership.xml 0000947871-23-000932 16747
2023-09-14 4 xslF345X05/ownership.xml 0000947871-23-000931 13047
2023-09-14 SC 13D/A AMENDMENT NO. 2 0000947871-23-000929 005-92449 231255319 34 150182
2023-09-12 424B5 424B5 0001193125-23-233462 333-274072 231250209 33 215874
2023-09-08 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-09-08 16:00:00 9999999995-23-002608 333-274072 231246557 33 1669
2023-09-06 CORRESP filename1.htm 0001193125-23-229644 5435
2023-08-18 D xslFormDX01/primary_doc.xml 06b 0001802806-23-000007 021-490181 231185849 33 15301
2023-08-18 S-3 S-3 0001193125-23-215941 333-274072 231185832 33 310167
2023-08-10 10-Q 10-Q 0000950170-23-040943 001-40287 231157129 34 7790301 1 1
2023-08-07 8-K 8-K 1.01,2.01,3.02,5.03,7.01,9.01 0001193125-23-204493 001-40287 231145714 34 1174628 1 1
2023-06-30 8-K 8-K 3.01 0001193125-23-180591 001-40287 231062696 34 155173 1 1
2023-06-13 4 FORM 4 SUBMISSION 0000899243-23-015449 5365
2023-06-13 4 FORM 4 SUBMISSION 0000899243-23-015448 5387
2023-06-13 4 FORM 4 SUBMISSION 0000899243-23-015446 5376
2023-06-13 4 FORM 4 SUBMISSION 0000899243-23-015450 5414
2023-06-13 4 FORM 4 SUBMISSION 0000899243-23-015447 5409
2023-06-13 4 FORM 4 SUBMISSION 0000899243-23-015444 5397
2023-06-13 4 FORM 4 SUBMISSION 0000899243-23-015445 6025
2023-06-09 8-K 8-K 5.07 0001193125-23-164481 001-40287 231005681 34 159635 1 1
2023-05-15 8-K 8-K 1.01,7.01,8.01,9.01 0001193125-23-144274 001-40287 23918881 34 14254326 1 1
2023-05-15 424B5 424B5 0001193125-23-144173 333-264517 23918383 33 468005
2023-05-15 10-Q 10-Q 0000950170-23-021909 001-40287 23918089 34 6946949 1 1
2023-04-28 ARS ARS 0001193125-23-124499 001-40287 23860472 34 14053561
2023-04-28 DEFA14A DEFA14A 0001193125-23-124491 001-40287 23860457 34 115005
2023-04-28 DEF 14A DEF 14A 0001193125-23-124483 001-40287 23860439 34 462632
2023-04-17 8-K 8-K 7.01,8.01,9.01 0001193125-23-103005 001-40287 23823015 34 13932883 1 1
2023-03-14 S-8 S-8 0001193125-23-069674 333-270518 23729257 33 64377
2023-03-14 10-K 10-K 0000950170-23-007681 001-40287 23729089 34 16390416 1 1
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-020713 005-92449 23622657 34 137914
2023-02-14 SC 13G/A AMENDMENT NO. 2 TO THE SCHEDULE 13G 0000921895-23-000474 005-92449 23620628 34 277073
2023-01-10 SC 13G/A filing.txt 0000315066-23-000020 005-92449 23520476 34 8049
2023-01-05 4 FORM 4 SUBMISSION 0000899243-23-000989 5422
2023-01-05 4 FORM 4 SUBMISSION 0000899243-23-000988 5388
2023-01-05 4 FORM 4 SUBMISSION 0000899243-23-000987 5420
2023-01-05 4 FORM 4 SUBMISSION 0000899243-23-000984 5340
2023-01-05 4 FORM 4 SUBMISSION 0000899243-23-000986 5406
2022-12-19 4 FORM 4 SUBMISSION 0000899243-22-039020 5242
2022-12-19 3 FORM 3 SUBMISSION 0000899243-22-039008 7583
2022-12-19 8-K 8-K 5.02,9.01 0001193125-22-308371 001-40287 221471615 34 175338 1 1
2022-11-28 8-K 8-K 7.01,8.01,9.01 0001193125-22-292953 001-40287 221421147 34 10986871 1 1
2022-11-10 8-K 8-K 7.01,8.01,9.01 0001193125-22-282059 001-40287 221375258 34 206703 1 1
2022-11-07 10-Q 10-Q 0000950170-22-022323 001-40287 221363731 34 7560119 1 1
2022-10-11 SC 13G/A filing.txt 0000315066-22-001788 005-92449 221302557 34 7860
2022-08-11 10-Q 10-Q 0000950170-22-016600 001-40287 221153485 34 7344149 1 1
2022-06-24 4 xslF345X03/ownership.xml 0000947871-22-000722 19184
2022-06-24 4 xslF345X03/ownership.xml 0000947871-22-000721 15468
2022-06-13 4 FORM 4 SUBMISSION 0000899243-22-022256 5344
2022-06-13 4 FORM 4 SUBMISSION 0000899243-22-022241 5333
2022-06-13 4 FORM 4 SUBMISSION 0000899243-22-022239 5386
2022-06-13 4 FORM 4 SUBMISSION 0000899243-22-022238 6028
2022-06-13 4 FORM 4 SUBMISSION 0000899243-22-022234 5377
2022-06-13 4 FORM 4 SUBMISSION 0000899243-22-022233 5365
2022-06-13 4 FORM 4 SUBMISSION 0000899243-22-022232 5382
2022-06-10 8-K FORM 8-K 5.07 0001193125-22-171517 001-40287 221007647 34 159063 1 1
2022-05-12 10-Q 10-Q 0000950170-22-009446 001-40287 22915522 34 6987397 1 1
2022-05-05 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-05-05 16:00:00 9999999995-22-001336 333-264517 22898658 33 1668
2022-05-03 CORRESP filename1.htm 0001193125-22-138795 5305
2022-05-02 UPLOAD filename1.pdf 0000000000-22-004772 40100
2022-04-27 S-3 S-3 0001193125-22-123919 333-264517 22860980 33 1279998
2022-04-27 DEFA14A DEFA14A 0001193125-22-123737 001-40287 22860325 34 770003
2022-04-27 DEF 14A DEF 14A 0001193125-22-123712 001-40287 22860169 34 857777
2022-04-25 4 FORM 4 SUBMISSION 0000899243-22-015586 5366
2022-04-25 3 FORM 3 SUBMISSION 0000899243-22-015584 7575
2022-04-13 8-K FORM 8-K 5.02,9.01 0001193125-22-103598 001-40287 22823632 34 189476 1 1
2022-04-06 8-K FORM 8-K 8.01 0001193125-22-096765 001-40287 22809357 34 148465 1 1
2022-03-17 S-8 S-8 0001193125-22-078328 333-263640 22748842 33 64895
2022-03-17 10-K 10-K 0000950170-22-003998 001-40287 22746669 34 12985115 1 1
2022-02-24 3 FORM 3 SUBMISSION 0000899243-22-007632 11197
2022-02-24 8-K FORM 8-K 5.02 0001193125-22-052216 001-40287 22671825 34 154437 1 1
2022-02-14 SC 13G SC 13G 0001193125-22-041265 005-92449 22630008 34 152117
2022-02-14 SC 13G/A AMENDMENT NO. 1 TO THE SCHEDULE 13G 0000921895-22-000530 005-92449 22628912 34 276770
2022-02-14 SC 13G/A IKENA ONCOLOGY, INC. 0001104659-22-021123 005-92449 22624594 34 139808
2022-02-11 SC 13D SCHEDULE 13D 0001387131-22-001711 005-92449 22622637 34 194650
2022-02-09 SC 13G/A filing.txt 0000315066-22-000991 005-92449 22604315 34 8304
2022-02-04 4 FORM 4 SUBMISSION 0000899243-22-004887 5423
2022-02-04 4 FORM 4 SUBMISSION 0000899243-22-004886 5425
2022-02-04 4 FORM 4 SUBMISSION 0000899243-22-004884 5384
2022-02-04 4 FORM 4 SUBMISSION 0000899243-22-004882 5391
2022-02-04 4 FORM 4 SUBMISSION 0000899243-22-004878 5385
2022-01-28 8-K FORM 8-K 5.02 0001193125-22-020673 001-40287 22565316 34 150634 1 1
2022-01-26 8-K FORM 8-K 5.02,9.01 0001193125-22-017680 001-40287 22555691 34 170393 1 1
2022-01-25 4 FORM 4 SUBMISSION 0000899243-22-003237 5257
2022-01-25 3 FORM 3 SUBMISSION 0000899243-22-003235 7597
2022-01-20 4 FORM 4 SUBMISSION 0000899243-22-002657 14705
2022-01-12 4 FORM 4 SUBMISSION 0000899243-22-001806 13985
2021-12-23 4 FORM 4 SUBMISSION 0000899243-21-049696 5303
2021-12-23 4 FORM 4 SUBMISSION 0000899243-21-049694 5265
2021-12-23 4 FORM 4 SUBMISSION 0000899243-21-049693 5917
2021-12-23 4 FORM 4 SUBMISSION 0000899243-21-049690 5254
2021-12-23 4 FORM 4 SUBMISSION 0000899243-21-049685 5307
2021-12-23 4 FORM 4 SUBMISSION 0000899243-21-049677 5298
2021-12-14 4 FORM 4 SUBMISSION 0000899243-21-048230 8524
2021-12-14 4 FORM 4 SUBMISSION 0001209191-21-069645 12849
2021-12-14 4 FORM 4 SUBMISSION 0001209191-21-069644 20279
2021-11-23 4 FORM 4 SUBMISSION 0000899243-21-045918 5415
2021-11-23 3 FORM 3 SUBMISSION 0000899243-21-045916 13259
2021-11-10 8-K FORM 8-K 7.01,9.01 0001193125-21-326102 001-40287 211397332 34 6736752 1 1
2021-11-10 10-Q 10-Q 0000950170-21-003871 001-40287 211394243 34 6699030 1 1
2021-08-16 SC 13D/A AMENDMENT NO. 1 0000947871-21-000939 005-92449 211179201 34 134105
2021-08-12 10-Q 10-Q 0001564590-21-043997 001-40287 211167873 34 6214763 1 1
2021-08-12 8-K 8-K 2.02,9.01 0001564590-21-043726 001-40287 211165998 34 203323
2021-05-13 10-Q 10-Q 0001564590-21-027555 001-40287 21919826 34 4891546 1
2021-05-13 8-K FORM 8-K 2.02,9.01 0001193125-21-159837 001-40287 21917228 34 65873
2021-05-03 4/A FORM 4/A SUBMISSION 0000899243-21-017841 5534
2021-04-15 4 FORM 4 SUBMISSION 0000899243-21-016001 5273
2021-04-15 3 FORM 3 SUBMISSION 0000899243-21-015995 7560
2021-04-15 8-K FORM 8-K 5.02,9.01 0001193125-21-117138 001-40287 21827309 34 37414
2021-04-15 SC 13D SCHEDULE 13D 0000947871-21-000427 005-92449 21826960 34 147107
2021-04-14 4/A xslF345X03/ownership.xml 0000947871-21-000426 41411
2021-04-13 4/A xslF345X03/ownership.xml 0000947871-21-000420 45055
2021-04-12 SC 13G filing.txt 0000315066-21-001500 005-92449 21820091 34 8251
2021-04-09 SC 13G SC 13G 0001104659-21-048782 005-92449 21818393 34 170398
2021-04-05 SC 13G SCHEDULE 13G 0001140361-21-011655 005-92449 21806748 34 101234
2021-04-05 SC 13G THE SCHEDULE 13G 0000921895-21-000937 005-92449 21806367 34 288247
2021-04-01 4 FORM 4 SUBMISSION 0000899243-21-014393 22301
2021-04-01 4 FORM 4 SUBMISSION 0000899243-21-014390 12397
2021-04-01 4 FORM 4 SUBMISSION 0000899243-21-014389 33712
2021-04-01 4 FORM 4 SUBMISSION 0000899243-21-014388 41868
2021-04-01 4 FORM 4 SUBMISSION 0000899243-21-014386 45281
2021-03-30 3/A FORM 3/A SUBMISSION 0000899243-21-013930 4720
2021-03-30 8-K 8-K 5.02,5.03,9.01 0001193125-21-100292 001-40287 21786716 34 156646
2021-03-30 S-8 S-8 0001193125-21-100264 333-254858 21786625 33 82156
2021-03-26 424B4 424B4 0001193125-21-096713 333-253919 21778348 33 5293218
2021-03-25 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-03-25 16:00:00 9999999995-21-001138 333-253919 21774469 33 1668
2021-03-25 3 FORM 3 SUBMISSION 0000899243-21-013558 9674
2021-03-25 3 FORM 3 SUBMISSION 0000899243-21-013557 15692
2021-03-25 3 FORM 3 SUBMISSION 0000899243-21-013555 10105
2021-03-25 3 FORM 3 SUBMISSION 0000899243-21-013553 12432
2021-03-25 3 FORM 3 SUBMISSION 0000899243-21-013552 11209
2021-03-25 3 FORM 3 SUBMISSION 0000899243-21-013551 17036
2021-03-25 3 FORM 3 SUBMISSION 0000899243-21-013546 15187
2021-03-25 3 FORM 3 SUBMISSION 0000899243-21-013545 24628
2021-03-25 3 FORM 3 SUBMISSION 0000899243-21-013543 13425
2021-03-25 3 FORM 3 SUBMISSION 0000899243-21-013542 9956
2021-03-25 3 FORM 3 SUBMISSION 0000899243-21-013541 18255
2021-03-25 3 FORM 3 SUBMISSION 0000899243-21-013534 13434
2021-03-25 SEC STAFF LETTER filename1.pdf 9999999997-21-001416 271831
2021-03-25 CERT 8A_Cert_IKNA.pdf 0001354457-21-000412 001-40287 21770370 34 333859
2021-03-23 8-A12B 8-A12B 0001193125-21-091158 001-40287 21764818 34 14968
2021-03-23 CORRESP filename1.htm 0001193125-21-091151 12215
2021-03-23 CORRESP filename1.htm 0001193125-21-091140 7385
2021-03-22 S-1/A S-1/A 0001193125-21-088609 333-253919 21760046 33 6878478
2021-03-12 CORRESP filename1.htm 0001193125-21-079866 60638
2021-03-05 CORRESP filename1.htm 0001193125-21-071325 10556
2021-03-05 S-1 S-1 0001193125-21-071313 333-253919 21718106 33 8664573
2021-03-01 SEC STAFF LETTER filename1.pdf 9999999997-21-000997 276899
2021-02-25 UPLOAD filename1.pdf 0000000000-21-002290 43355
2021-02-11 DRSLTR filename1.htm 0000950123-21-001692 43062
2021-02-11 DRS/A filename1.htm 0000950123-21-001690 377-04000 21621044 33 7665262
2021-02-08 UPLOAD filename1.pdf 0000000000-21-001545 56338
2021-01-08 DRS filename1.htm 0000950123-21-000138 377-04000 21517196 33 6092095

Latest XBRL company facts

One latest value per concept from companyfacts (318 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 12.46M 2026-10-31 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
dei EntityPublicFloat Entity Public Float USD 41.70M 2025-06-30 2025 FY 10-K 2026-03-10 0001193125-26-099434
ffd NetFeeAmt NetFeeAmt USD 4,438.64 2026-08-04 S-3 2026-08-05 0001193125-26-335163
ffd TtlFeeAmt TtlFeeAmt USD 4,438.64 2026-08-04 S-3 2026-08-05 0001193125-26-335163
ffd TtlOfferingAmt TtlOfferingAmt USD 32.14M 2026-08-04 S-3 2026-08-05 0001193125-26-335163
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-04 S-3 2026-08-05 0001193125-26-335163
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-08-04 S-3 2026-08-05 0001193125-26-335163
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 931,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 13,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 5.83M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 1.01M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 0 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -170,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 394.77M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock USD -3.05M 2025-01-01 2025-03-31 2026 Q1 10-Q 2026-05-07 0001193125-26-212073
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 1.67M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 3.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 3.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable USD 13.89M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-17 0000950170-22-003998
us-gaap Assets Assets USD 142.54M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap AssetsCurrent Assets, Current USD 130.60M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 0 2024-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 170,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 41.91M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 33.34M 2023-12-31 2023 FY 10-K 2024-03-12 0000950170-24-029651
us-gaap AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost USD 28.55M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value USD 28.47M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Remainder of Fiscal Year USD 27.81M 2026-06-30 2026 Q2 10-Q 2026-08-05 0001193125-26-333920
us-gaap AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Remainder of Fiscal Year USD 27.80M 2026-06-30 2026 Q2 10-Q 2026-08-05 0001193125-26-333920
us-gaap AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value USD 41.74M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost USD 41.91M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One USD 13.72M 2026-06-30 2026 Q2 10-Q 2026-08-05 0001193125-26-333920
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 13.68M 2026-06-30 2026 Q2 10-Q 2026-08-05 0001193125-26-333920
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 41.74M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 94.60M 2023-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-061535
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 259,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-12 0000950170-24-029651
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 3.69M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-17 0000950170-22-003998
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 84.85M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 126.60M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 84.85M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 18.90M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-07-24 0000950170-25-098414
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -9.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap CashDivestedFromDeconsolidation Cash Divested from Deconsolidation USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 3.30M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 150.00M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 48.26M 2025-06-30 2025 Q2 10-Q 2025-07-24 0000950170-25-098414
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 48.26M 2025-06-30 2025 Q2 10-Q 2025-07-24 0000950170-25-098414
us-gaap CommonStockValue Common Stock, Value, Issued USD 48,000 2025-06-30 2025 Q2 10-Q 2025-07-24 0000950170-25-098414
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -36.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 9.16M 2022-12-31 2023 FY 10-K 2024-03-12 0000950170-24-029651
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 7.68M 2021-12-31 2022 FY 10-K 2023-03-14 0000950170-23-007681
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 3.16M 2025-07-25 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD -383,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD -350,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 33,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap DebtCurrent Debt, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLoss Debt Securities, Available-for-sale, Allowance for Credit Loss USD 0 2025-06-30 2025 Q2 10-Q 2025-07-24 0000950170-25-098414
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 13.13M 2023-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-061535
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss USD 22,500 2023-12-31 2023 FY 10-K 2024-03-12 0000950170-24-029651
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions Position 4 2023-12-31 2023 FY 10-K 2024-03-12 0000950170-24-029651
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 57.54M 2023-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-061535
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss USD 176,000 2023-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-061535
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD -12,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-12 0000950170-24-029651
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 70.68M 2023-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-061535
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss USD 292,000 2023-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-061535
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions Position 23 2023-12-31 2023 FY 10-K 2024-03-12 0000950170-24-029651
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 220,000 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 0 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 52,000 2025-09-30 2025 Q3 10-Q 2025-11-12 0001193125-25-275932
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap DeferredTaxAssetsCapitalLossCarryforwards Deferred Tax Assets, Capital Loss Carryforwards USD 27.39M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 2.50M 2022-12-31 2023 FY 10-K 2024-03-12 0000950170-24-029651
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 91.78M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 101.22M 2023-12-31 2023 FY 10-K 2024-03-12 0000950170-24-029651
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 220,000 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 60.91M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 40.22M 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034188
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 13.14M 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034188
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 2.55M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 16.34M 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034188
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 934,000 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 492,000 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034188
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 91.56M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 221,000 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD -1,000 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 140,000 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034188
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 400,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034188
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 4.88M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap Depreciation Depreciation USD 174,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-07-24 0000950170-25-098414
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 400,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap DividendsCommonStock Dividends, Common Stock USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-17 0000950170-22-003998
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -2.45 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.47 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009446
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -2.45 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.007 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.044 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.09 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.01 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure 0.051 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-17 0000950170-22-003998
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.057 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.001 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034188
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure -0.011 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.01 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.012 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 2.51M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 16.50M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 11.90M 2026-03-31 2026 Q1 10-Q 2026-05-07 0001193125-26-212073
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2021-12-31 2021 FY 10-K 2022-03-17 0000950170-22-003998
us-gaap FairValueAssetsLevel2ToLevel1TransfersAmount Fair Value, Assets, Level 2 to Level 1 Transfers, Amount USD 0 2021-12-31 2021 FY 10-K 2022-03-17 0000950170-22-003998
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap GainLossOnSaleOfProperties Gain (Loss) on Sale of Properties USD -99,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-13 0000950170-24-058715
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap GainLossOnTerminationOfLease Gain (Loss) on Termination of Lease USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 17.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0000950170-24-029651
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 0 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-07-24 0000950170-25-098414
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -34.63M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -36.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -11.07M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 23,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 46,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 2.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -9.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 3,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 2.62M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD 486,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 37,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 564,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -654,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -7.66M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0000950170-24-029651
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 1.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap IncreaseDecreaseInDepositOtherAssets Increase (Decrease) in Deposit Assets USD -940,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-07-24 0000950170-25-098414
us-gaap IncreaseDecreaseInLeasingReceivables Increase (Decrease) in Leasing Receivables USD 2.09M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0000950170-24-029651
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -1.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 1.21M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD -22,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -939,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap IncreaseInCarryingAmountOfRedeemablePreferredStock Increase in Carrying Amount of Redeemable Preferred Stock USD 846,000 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap IncrementalCommonSharesAttributableToConversionOfPreferredStock Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock shares 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-07 0001193125-26-212073
us-gaap InterestExpenseOperating InterestExpenseOperating USD 489,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 3.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 7.11M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0000950170-24-029651
us-gaap InvestmentIncomeNet Investment Income, Net USD 2.71M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-07-24 0000950170-25-098414
us-gaap InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures USD 942,000 2024-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap LaborAndRelatedExpense Labor and Related Expense USD 5.18M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap LeaseCost Lease, Cost USD 4.30M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034188
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.078 2023-12-31 2023 FY 10-K 2024-03-12 0000950170-24-029651
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 3.13M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 2.42M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 817,000 2021-12-31 2021 FY 10-K 2022-03-17 0000950170-22-003998
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 719,000 2023-12-31 2023 FY 10-K 2024-03-12 0000950170-24-029651
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 720,000 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034188
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 719,000 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 436,000 2021-09-30 2021 Q3 10-Q 2021-11-10 0000950170-21-003871
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 160,000 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap Liabilities Liabilities USD 14.40M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 142.54M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap LiabilitiesCurrent Liabilities, Current USD 8.07M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 0 2024-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap LossContingencyNewClaimsFiledNumber Loss Contingency, New Claims Filed, Number Action 2 2025-06-01 2025-06-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 41.74M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap NetCashProvidedByUsedInContinuingOperations Net Cash Provided by (Used in) Continuing Operations USD 13.20M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-13 0001564590-21-027555
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 24.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -1.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -33.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -36.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -36.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -36.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1 Noncash or Part Noncash Acquisition, Value of Assets Acquired USD 34,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-17 0000950170-22-003998
us-gaap NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1 Noncash or Part Noncash Acquisition, Value of Liabilities Assumed USD 970,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-17 0000950170-22-003998
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 4.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap OperatingExpenses Operating Expenses USD 41.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -41.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap OperatingLeaseCost Operating Lease, Cost USD 1.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 1.07M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-07-24 0000950170-25-098414
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 2.98M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.31M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap OperatingLeasePayments Operating Lease, Payments USD 1.25M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 345,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 526,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.086 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 164,000 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap OtherAssetsCurrent Other Assets, Current USD 1.15M 2023-12-31 2023 FY 10-K 2024-03-12 0000950170-24-029651
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 4.88M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD -29,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -3,000 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -34,000 2025-04-01 2025-06-30 2025 Q2 10-Q 2025-07-24 0000950170-25-098414
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -257,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap OtherGeneralAndAdministrativeExpense Other General and Administrative Expense USD 4.19M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 268,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 848,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap OtherLongTermDebtNoncurrent Other Long-term Debt, Noncurrent USD 1.06M 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034188
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 22,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-12 0000950170-24-029651
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 172,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009446
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 1.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 1.51M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 1.30M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale USD 0 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-061535
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 663,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034188
us-gaap PaymentsForRestructuring Payments for Restructuring USD 1.23M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-07-24 0000950170-25-098414
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 56,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap PaymentsToAcquireLoansReceivable Payments to Acquire Loans Receivable USD 15.00M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-07-24 0000950170-25-098414
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 24.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 414,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034188
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 4.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap PrepaidInsurance Prepaid Insurance USD 565,000 2023-12-31 2023 FY 10-K 2024-03-12 0000950170-24-029651
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 131.30M 2021-03-30 2023 FY 10-K 2024-03-12 0000950170-24-029651
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 37.42M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034188
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 23.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap ProceedsFromSaleOfAvailableForSaleSecuritiesDebt Proceeds from Sale of Debt Securities, Available-for-sale USD 37.40M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-07-24 0000950170-25-098414
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 146,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 41,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -36.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 0 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap RedeemableNoncontrollingInterestEquityCarryingAmount Redeemable Noncontrolling Interest, Equity, Carrying Amount USD 159.04M 2024-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap RedeemableNoncontrollingInterestEquityPreferredCarryingAmount Redeemable Noncontrolling Interest, Equity, Preferred, Carrying Amount USD 159.04M 2024-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned Research and Development Arrangement, Contract to Perform for Others, Compensation Earned USD 1.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 23.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 11.14M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-17 0000950170-22-003998
us-gaap RestrictedCash Restricted Cash USD 900,000 2025-06-30 2025 Q2 10-Q 2025-07-24 0000950170-25-098414
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 1.28M 2024-03-31 2024 Q1 10-Q 2024-05-13 0000950170-24-058715
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 872,000 2025-06-30 2025 Q2 10-Q 2025-07-24 0000950170-25-098414
us-gaap RestructuringCharges Restructuring Charges USD 1.74M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-07-24 0000950170-25-098414
us-gaap RestructuringReserve Restructuring Reserve USD 340,000 2025-06-30 2025 Q2 10-Q 2025-07-24 0000950170-25-098414
us-gaap RestructuringReserveSettledWithoutCash2 Restructuring Reserve, Settled without Cash USD 176,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-07-24 0000950170-25-098414
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -266.47M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 800,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 800,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 178,000 2020-01-01 2020-09-30 2021 Q3 10-Q 2021-11-10 0000950170-21-003871
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 16 2021-03-30 2023 FY 10-K 2024-03-12 0000950170-24-029651
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 3.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.028 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.86 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-14 0000950170-23-007681
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.836 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-14 0000950170-23-007681
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.04 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.036 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-14 0000950170-23-007681
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.017 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-14 0000950170-23-007681
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 2.03M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 380,086 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 4.44 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 13,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 66,016 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 704,544 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.1 2024-01-01 2024-06-30 2025 Q2 10-Q 2025-07-24 0000950170-25-098414
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 2.19M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 1.12M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 10.15 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 2.19M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 1.12M 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 10.15 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 22.68 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 4.66 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 13.12 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 128.14M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap StockholdersEquityNoteSpinoffTransaction Stockholders' Equity Note, Spinoff Transaction USD -6.72M 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.14 2021-03-22 2021 FY 10-K 2022-03-17 0000950170-22-003998
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 1,763 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 14.11M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034188
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 166.09M 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 41,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 83.03M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 111,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 663,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034188
us-gaap TemporaryEquityAccretionToRedemptionValue Temporary Equity, Accretion to Redemption Value USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap TemporaryEquityAccretionToRedemptionValueAdjustment Temporary Equity, Accretion to Redemption Value, Adjustment USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 216.26M 2021-06-30 2022 Q2 10-Q 2022-08-11 0000950170-22-016600
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 0 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 0 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 901,000 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 13,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities USD 0 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-14 0000950170-23-007681
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 48,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 715,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap UnrecognizedTaxBenefitsPeriodIncreaseDecrease Unrecognized Tax Benefits, Period Increase (Decrease) USD 927,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034188
us-gaap UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations USD 162,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 1.00M 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034188
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 57.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001193125-26-099434
us-gaap VariableLeaseCost Variable Lease, Cost USD 1.54M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034188
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 14.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 36.08M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009446
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 14.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001193125-26-453624

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →